SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zydus Lifesciences informs about analyst meet

23 Jul 2024 Evaluate
Zydus Lifesciences has informed that the financial results of Zydus Lifesciences for Q1 2024-25 (April-June 2024)will be declared on August 9, 2024. Post results Q&A session through webinar has been scheduled on the same day, August 9, 2024 at 3:30 pm Sharvil Patel, Managing Director, Zydus Lifesciences would be hosting the call. The details to join the call is provided in the attached.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

927.15 -19.95 (-2.11%)
24-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.95
Dr. Reddys Lab 1315.85
Cipla 1294.75
Zydus Lifesciences 927.15
Lupin 2296.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×